|
Rivera-Caravaca JM, Camelo-Castillo A, Ramirez-Macias I, Gil-Perez P, Lopez-Garcia C, Esteve-Pastor MA, Orenes-Pinero E, Tello-Montoliu A, Marin F. Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation. Int J Mol Sci. 2021 Jul 1;22(13):7113. doi: 10.3390/ijms22137113. PubMed PMID: 34281167; PubMed Central PMCID: PMC8267774.
AÑO: 2021; IF: 6.208
|
34281167
|
Fernandez MS, Marin F, Rafols C, Arribas F, Barrios V, Cosin-Sales J, Sanchez MA; the EMIR Study Investigators:. Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study). J Comp Eff Res. 2021 May;10(7):583-593. doi: 10.2217/cer-2020-0286. Epub 2021 Mar 31. PubMed PMID: 33787316.
AÑO: 2021; IF: 2.04
|
|
Proietti M, Vitolo M, Harrison SL, Lane DA, Fauchier L, Marin F, Nabauer M, Potpara TS, Dan GA, Boriani G, Lip GYH; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry. BMC Med. 2021 Oct 20;19(1):256. doi: 10.1186/s12916-021-02120-3. PubMed PMID: 34666757; PubMed Central PMCID: PMC8527730.
AÑO: 2021; IF: 11.15
|
|
Sanchez-Fuentes A, Rivera-Caravaca JM, Lopez-Galvez R, Marin F, Roldan V. Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics. Front Cardiovasc Med. 2022 Jan 17;8:787235. doi: 10.3389/fcvm.2021.787235. eCollection 2021. PubMed PMID: 35111826; PubMed Central PMCID: PMC8801490.
AÑO: 2021; IF: 5.846
|
|
SEC Working Group for the 2020 ESC Guidelines for the Management of Atrial Fibrillation; Expert Reviewers for the 2020 ESC Guidelines for the Management of Atrial Fibrillation; SEC Guidelines Committee; Working Group for the 2020 ESC guidelines for the management of atrial fibrillation; Expert reviewers for the 2020 ESC guidelines for the management of atrial fibrillation; SEC Guidelines Committee. Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation. Rev Esp Cardiol (Engl Ed). 2021 May;74(5):378-383. doi: 10.1016/j.rec.2020.11.023. Epub 2021 Mar 15. No abstract available. English, Spanish. PubMed PMID: 33736964.
AÑO: 2021
|